---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-135860"
form_type: "8-K"
ticker: "AMLX"
cik: "0001658551"
company_name: "Amylyx Pharmaceuticals, Inc."
filed_at: "2025-06-05T23:59:59+00:00"
generated_at: "2026-05-19T22:06:45.901585+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Amylyx shareholders elect three Class I directors; ratify Deloitte; approve say-on-pay proposal

## Summary
- Karen Firestone, Justin Klee, and Bernhardt Zeiher elected as Class I directors for term ending 2028. Firestone and Zeiher each had ~21.3M votes withheld; Klee had 1.5M.
- Ratification of Deloitte & Touche as auditor for FY 2025 passed with 72.5M for vs 34.7K against.
- Non-binding advisory vote on executive compensation passed with 33.1M for, 24.1M against, and 2.0M abstentions.
- Total shares voted: ~72.5M on auditor proposal; broker non-votes of 15.4M on director elections and say-on-pay.

## SEC filing metadata
- accession: 0001193125-25-135860
- form_type: 8-K
- ticker: AMLX
- cik: 0001658551
- company_name: Amylyx Pharmaceuticals, Inc.
- filed_at: 2025-06-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1658551/000119312525135860/0001193125-25-135860-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1658551/000119312525135860/d920336d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-135860
- JSON: https://secwatch.observer/filing/0001193125-25-135860.json
- Plain text: https://secwatch.observer/filing/0001193125-25-135860.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.